JAMES A. CURTIN, M.D.; ROBERT G. PETERSDORF, M.D.; IVAN L. BENNETT JR., M.D., F.A.C.P.
For several reasons, the role of bacteria of the Pseudomonas group in human disease has received increasing attention in recent years.1-5 Antimicrobial drugs have reduced morbidity and mortality from many infections and have virtually eliminated several common pathogenic microorganisms as major threats to life. It is not surprising that therapeutic efforts now tend to focus upon those microbial species that remain poorly controlled by chemotherapy. With the possible exception of the hemolytic staphylococcus, the coliform and related gram-negative bacteria have been the most troublesome because of their irregular susceptibility to the drugs now available.6, 7 Among these bacilli, Pseudomonas
CURTIN JA, PETERSDORF RG, BENNETT IL. PSEUDOMONAS BACTEREMIA: REVIEW OF NINETY-ONE CASES1. Ann Intern Med. ;54:1077–1107. doi: 10.7326/0003-4819-54-6-1077
Download citation file:
Published: Ann Intern Med. 1961;54(6):1077-1107.
Infectious Disease, Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use